Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micap was a United Kingdom-based biotechnology company that specialized in the development of microencapsulation technology using yeast cells (Saccharomyces cerevisiae). The company's proprietary platform utilized the natural structure of yeast cell walls to encapsulate and protect active ingredients, such as pharmaceuticals, agrochemicals, and flavors, for controlled release and improved stability. While Micap was once listed on the London Stock Exchange's AIM market, it faced financial challenges and its intellectual property was eventually acquired by Eden Research plc. The technology remains significant in the field of natural, biodegradable delivery systems and is currently marketed under the Sustaine brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micap.